FYI Resources Limited (SDL.F)
| Previous Close | 0.0860 |
| Open | 0.0860 |
| Bid | 0.0859 x 0 |
| Ask | 0.0999 x 0 |
| Day's Range | 0.0860 - 0.0860 |
| 52 Week Range | 0.0860 - 0.3080 |
| Volume | |
| Avg. Volume | 2,389 |
| Market Cap | 35.132M |
| Beta (5Y Monthly) | 1.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0080 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
We're Hopeful That FYI Resources (ASX:FYI) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Business Wire
McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
IRVING, Texas, June 29, 2022--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
- Business Wire
McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research
IRVING, Texas & NASHVILLE, Tenn., June 23, 2022--McKesson Corporation (NYSE: MCK) and HCA Healthcare, Inc. (NYSE: HCA) announced today an agreement to form a joint venture combining McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (SCRI). USOR is the research arm of McKesson’s The US Oncology Network and draws from a network of experienced investigators and dedicated clinical staff who specialize in oncology clinical trials. SCRI, which is the research
